If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 33 Similar Profiles
docetaxel Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Cells Chemical Compounds
zoledronic acid Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 921 Citations
  • 19 h-Index
  • 44 Article
  • 1 Review article

Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians

Storci, G., De Carolis, S., Papi, A., Bacalini, M. G., Gensous, N., Marasco, E., Tesei, A., Fabbri, F., Arienti, C., Zanoni, M., Sarnelli, A., Santi, S., Olivieri, F., Mensà, E., Latini, S., Ferracin, M., Salvioli, S., Garagnani, P., Franceschi, C. & Bonafè, M., Jan 8 2019, In : Cell Death and Differentiation. p. 1-14 14 p.

Research output: Contribution to journalArticle

Genomic Instability
Interferon Type I
Anti-Inflammatory Agents
Up-Regulation
DNA Damage

Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer

Pietri, E., Massa, I., Bravaccini, S., Ravaioli, S., Tumedei, M. M., Petracci, E., Donati, C., Schirone, A., Piacentini, F., Gianni, L., Nicolini, M., Campadelli, E., Gennari, A., Saba, A., Campi, B., Valmorri, L., Andreis, D., Fabbri, F., Amadori, D. & Rocca, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Dehydroepiandrosterone
Androgen Receptors
Breast Neoplasms
Estrogen Receptors
Aromatase Inhibitors
Circulating Neoplastic Cells
Fluorescence In Situ Hybridization
Fluorescent Antibody Technique
Tumors
DNA
1 Citation (Scopus)
Ploidies
S Phase
Ovarian Neoplasms
Carcinoma
Drug Therapy
2 Citations (Scopus)

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

Rocca, A., Cecconetto, L., Passardi, A., Melegari, E., Andreis, D., Monti, M., Maltoni, R., Sarti, S., Pietri, E., Schirone, A., Fabbri, F., Donati, C., Nanni, O., Fedeli, A., Faedi, M. & Amadori, D., May 1 2017, In : Cancer Chemotherapy and Pharmacology. 79, 5, p. 863-871 9 p.

Research output: Contribution to journalArticle

Toxicity
Breast Neoplasms
Diarrhea
Hand-Foot Syndrome
Anthracyclines